SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a major focal point for traders due to its recent surge in social media volume and discussion surrounding its post-quantum security features. Community members remain polarized, with many debating the impact of institutional-grade infrastructure upgrades and potential regulatory shifts while long-term holders focus on accumulation during significant price volatility.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention as investors monitor its lead clinical candidate, AVTX-009, with the community actively discussing potential Phase 2 trial readouts and bullish analyst coverage that underscores its long-term upside. Market participants are closely watching the high trading volume and volatility, while simultaneously expressing caution over the companys ongoing capital requirements and historical dependence on successful clinical data.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petroleo Brasileiro (PBR) is trending as investors weigh strong production milestones and offshore expansion plans against ongoing concerns regarding political interference and fluctuating oil price environments. The community remains focused on the stock's potential for significant dividend payouts and its status as a value play, while closely monitoring geopolitical risks and regulatory hurdles affecting its deepwater drilling prospects.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is currently a major focus for traders as the stock attempts a recovery following a multi-year downtrend, with community sentiment split between those viewing it as a deep-value turnaround play and others concerned about long-term margin pressure from labor costs and losing Amazon volume. Investors are actively monitoring the stock's consolidation around the $100 level, looking for signs that restructuring efforts and cost-cutting can successfully defend the dividend and drive a sustained breakout.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing heightened volatility as investors weigh the impact of shifting rate expectations and rotation out of speculative growth assets. Community discussion is sharply divided between those tracking Cathie Wood's tactical shifts in and out of crypto-linked stocks and critics focusing on the fund's long-term performance struggles.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is currently a focal point for the community due to major structural updates like Mission 70aimed at reducing token inflationand increasing adoption through sovereign subnets in regions like Switzerland and Pakistan. While some users remain skeptical due to historical volatility and the project's long-term performance, many community members are highlighting the real-world utility of platforms like Caffeine.ai and the growing number of canisters as indicators that the network's fundamentals are strengthening for a future recovery.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a major management shake-up where long-time CEO Peter Greenleaf was replaced by board chair Kevin Tang, a move that investors view as a pivotal step toward unlocking shareholder value and accelerating potential acquisition efforts. The community is actively discussing the leadership transition, Tang's significant investment with no compensation, and the expectation that the new team will prioritize a strategic sale or partnership.

FLOKI is a community-driven, multi-chain utility token that powers a broad ecosystem including decentralized gaming, finance, and educational platforms. Originally evolving from a meme-based asset, the project now focuses on a utility-driven model centered around three pillars: community engagement, technical utility, and global charity work, balancing this ecosystem growth with social impact, such as building schools in developing nations like Ghana and Nigeria.  Key features include Valhalla, an NFT metaverse game where the token serves as the primary currency for capturing creatures and upgrading characters. The ecosystem also features the FlokiFi Locker for securing digital assets and the University of FLOKI for web3 education,with real-world integration facilitated through a prepaid debit card for everyday purchases at global stores. Staking FLOKI allows users to earn rewards in a sister token.  The project is led by a group of core advisors known by pseudonyms such as Sabre and B (The Viking) and is officially backed by DWF Labs, a major digital asset investment firm and market maker. While a small tax on decentralized trades helps fund development, value moves through the system as users utilize the token to pay for in-game items, access asset-locking services, or purchase merchandise.

Floki Token

$FLOKI is seeing increased activity as the community celebrates the launch of its ETP in Europe, which is being viewed as a significant milestone for institutional accessibility. Traders are currently split between long-term optimism about the token's ecosystem developmentssuch as gaming and DeFi toolsand frustration over recent price volatility that has left many questioning the current market trend.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is currently experiencing heightened volatility and intense community scrutiny following a sharp share price decline triggered by analyst downgrades and broader tech sector rotation, despite a significant new partnership agreement with Amazon. Investors are actively debating whether this pullback represents an attractive long-term buying opportunity or a deeper structural issue, with many focusing on the company's role as a critical link in the AI infrastructure build-out.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as the community eagerly awaits definitive biomarker data and regulatory updates regarding an accelerated approval pathway for its ALS candidate, CNM-Au8. Investors are closely monitoring upcoming conference presentations and regulatory milestones, balancing high-conviction long-term sentiment against volatility driven by short interest and recent insider selling activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Barclays analyst Tom O'Malley raised the firm's price target on Arm to $200 from $165 and kept an ‘Overweight’ rating on the shares.</li><li>RBC Capital said that Arm’s much-anticipated full-chip strategy will complement its IP business.</li><li>Arm on Tuesday had announced that it is extending into&nbsp;the&nbsp;production of silicon products for the first time in its history.&nbsp;</li></ul>Shares of Arm Holdings (ARM) closed 16% higher on Wednesday as several analysts were buoyed by the company's outlook as well as its first company-designed data center CPU.&nbsp;Arm on Tuesday had announced that it is extending into&nbsp;the production of silicon products for the first time in its history with the launch of the Arm AGI CPU, an Arm-designed CPU for AI data centers, built to address a rising class of agentic AI workloads.Arm CEO Rene Haas reportedly told Bloomberg in an interview on Tuesday that the company expects its own chips business to generate about $15 billion in annual sales in five years. Meta Platforms (META) will be the first major customer for the company's new AGI CPU chip.<h2 class="st-heading-2">Bullish Wall Street</h2>Raymond James&nbsp;subsequently upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's announced business model shift to include a fabless semiconductor element for the upgrade, per TheFly.&nbsp;Barclays analyst Tom O'Malley raised the firm's price target on Arm to $200 from $165 and kept an ‘Overweight’ rating on the shares. The "Arm Everywhere" event made it clear that CPUs play a very important role in agentic AI and the company's solution is the AGI CPU, which "plays to ARM's strength in energy efficiency," the analyst told investors.RBC Capital also raised the firm's price target on Arm to $175 from $130 and kept an ‘Outperform’ rating on the shares. The firm cited the company's much-anticipated full-chip strategy, which the management believes will complement its IP business, the analyst told investors in a research note. The strategy offers significant revenue growth and earnings potential over the long term but comes with gross margin dilution and channel conflict issues, RBC Capital added.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around ARM trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have risen 39% so far in 2026.&nbsp;

The replica of the ARM is an electronic chip board during a collaborative ceremony launching a partnership between Malaysia and ARM Holdings in Kuala Lumpur, Malaysia, on March 5, 2025. 

Why Did Arm Stock Close 16% Higher Today?

Raymond James upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's business model shift to include a fabless semiconductor element for the upgrade.

Equity

Raymond James upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's business model shift to include a fabless semiconductor element for the upgrade.


Is First Trust NASDAQ-100-Technology Sector ETF (QTEC) a Strong ETF Right Now?

Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?

Worried About Oracle's Downfall? Hedge With These 5 Top-Ranked Tech ETFs

Oracle's selloff, tied to AI spending and debt fears, has rattled investors. Diversifying with top tech ETFs like XLK could help mitigate single-stock risk.

MongoDB (MDB) shares tumbled as much as 19% in pre-market trade on Thursday after issuing underwhelming guidance for fiscal 2026, triggering a downgrade from Wells Fargo and a wave of price target cuts across Wall Street.The database software company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mongodb-plummets-aftermarket-as-guidance-misses-estimates/cheFYBNR68">reported</a> fourth-quarter (Q4) earnings per share (EPS) of $1.28, nearly doubling analysts’ expectations of $0.66.&nbsp;Revenue came in at $548.4 million, exceeding estimates of $519.84 million.Despite the strong results, Wall Street seems rattled by MongoDB’s outlook.&nbsp;The company projected fiscal 2026 revenue between $2.24 billion and $2.28 billion, falling short of the consensus estimate of $2.32 billion.&nbsp;Earnings guidance&nbsp;is forecast between&nbsp;$2.44 and $2.62, well below Wall Street’s estimate of $3.39.Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target by more than $100 to $225 from $365.The brokerage noted that MongoDB’s guidance and slowing multi-year deals suggest a challenging fiscal 2026.&nbsp;Wells Fargo views the upcoming year as a “transition period” for the company, warning that revenue growth will “significantly decelerate” and limit the stock’s upside.It added that MongoDB is still in the early stages of monetization, with Atlas starting to see further stabilization in its note to investors.&nbsp;Atlas revenue contributed to 68% of MongoDB's topline and climbed 32.6% year-over-year, outpacing overall company growth.Other major firms, including Barclays, Bank of America, Morgan Stanley, and Piper Sandler, maintained their ‘Buy’-equivalent ratings but reduced their price targets,&nbsp;citing the weak guidance, according to TheFly.<figure class="image"><img style="aspect-ratio:1296/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_06_073150_b10033171b.png" alt="Screenshot 2025-03-06 073150.png" width="1296" height="314"><figcaption>MongoDB retail sentiment and message volume on March 6 as of 7:30 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MDB">MongoDB’s stock</a> surged to ‘extremely bullish’ from ‘neutral’ a day ago, despite Wall Street’s pessimism.Retail chatter jumped to&nbsp;year highs,&nbsp;rising to ‘extremely high’ levels.Some users questioned why MongoDB consistently issues conservative guidance even though its earnings often align with estimates.<stembedurl>https://stocktwits.com/TheVoic/message/606971120</stembedurl>One user speculated that the stock may struggle to recover if the company continues to report negative profit margins and weak guidance each quarter.<stembedurl>https://stocktwits.com/Ranga14r/message/606969034</stembedurl>MongoDB shares have lost nearly 40% over the past year but remain up 12% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/traders-buy-strategy-stock-ahead-michael-saylor-at-trump-white-house-crypto-summit/cheF6mgR6U">Retail Traders Bet Big On Strategy’s Stock Ahead Of Michael Saylor’s Appearance At Trump’s White House Crypto Summit</a> &nbsp;

Mongodb Headquarters (Photo via Smith Collection/Gado/Getty Images).

MongoDB Stock Sinks Pre-Market As Weak Guidance Spawns Downgrade, Price Target Cuts – But Retail Isn’t Worried

Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target by more than $100 to $225 from $365.

Arm Holdings stock&nbsp;declined over 7%, while shares of Qualcomm rose over 2% after the latter won the legal dispute between the two companies.This marks a 4-month low for Arm, which was last seen trading at these levels in September.Over the weekend, a U.S. federal court sided with Qualcomm after a week-long trial, ruling that its licensing agreement with Arm remained intact despite claims of a breach.&nbsp;The dispute arose after Qualcomm acquired Nuvia, a startup that utilizes Arm's architecture in chip design.&nbsp;Arm alleged that Qualcomm owed higher royalties because Nuvia’s products fell under Qualcomm's umbrella, thus broadening its reliance on Arm’s patents.<figure class="image"><img style="aspect-ratio:1302/289;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_23_101118_e1d8a7efde.png" alt="Screenshot 2024-12-23 101118.png" width="1302" height="289"><figcaption>Arm Sentiment and Message Volume on Dec 23 as of 10:05 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around Arm remained ‘neutral,’ with chatter increasing to ‘normal’ from ‘low’ levels as users debated whether Qualcomm's partial win had impacted the status quo.&nbsp;<stembedurl>https://stocktwits.com/Vikingmilkman/message/597590709</stembedurl><stembedurl>https://stocktwits.com/jjg111/message/597587654</stembedurl><stembedurl>https://stocktwits.com/Bee4ev/message/597576980</stembedurl>The jury’s decision, however, wasn’t a complete win for Qualcomm. While the court determined no violation of the licensing terms, the jury couldn’t unanimously agree on whether Nuvia had breached its contract with Arm.&nbsp;This leaves room for further legal battles as Arm evaluates its options&nbsp;(suggest attributing this line to some source. Slightly sensitive). But at least for now, Qualcomm is off the hook, lifting retail sentiment.&nbsp;<figure class="image"><img style="aspect-ratio:1290/297;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_23_100946_f1fcb2bf39.png" alt="Screenshot 2024-12-23 100946.png" width="1290" height="297"><figcaption>Qualcomm Sentiment and Message Volume on Dec 23 as of 10:05 a.m. ET | Source: Stocktwits</figcaption></figure>While chatter around Qualcomm increased to ‘normal’ from ‘low’ a day ago, sentiment improved to ‘bullish’ from the ‘neutral’ zone.&nbsp;“We are pleased with today’s decision. The jury has vindicated Qualcomm’s right to innovate and affirmed that all the Qualcomm products at issue in the case are protected by Qualcomm’s contract with ARM,” the company said in a statement.“We will continue to develop performance-leading, world class products that benefit consumers worldwide, with our incredible Oryon ARM-compliant custom CPUs,” it added.<a href="https://stocktwits.com/symbol/ARM">Arm Holdings</a> is yet to comment on the verdict.&nbsp;Despite Arm’s dip&nbsp;on Monday, the stock is up over 81% year-to-date, far higher than Qualcomm’s 11% gains&nbsp;in the period.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/arm-stock-slips-as-legal-battle-with-qualcomm-kicks-off-in-delaware/cJaltZYR1L">Arm Stock Slips As Court Room Battle With Qualcomm Kicks Off In Delaware: Retail Divided</a>

POLAND - 2023/09/19: In this photo illustration, the Arm Holdings logo seen displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Arm Stock Slides To 4-Month Low As Qualcomm Jumps On Victory In Licensing Dispute: Retail Remains Unswayed

The jury’s decision, however, wasn’t a complete win for Qualcomm leaving room for further legal battles as Arm evaluates its options.

Super Micro Computer, Inc. ($SMCI) stock pulled back sharply on Tuesday, a day after traders bid up the stock on the relief that the artificial intelligence server maker dodged the delisting bullet, at least for now.At last check, the stock was down 8.26% at $40.51, having traded in the $39.78&nbsp;to&nbsp;$43.35 range.Late Friday,&nbsp;Super Micro&nbsp;confirmed that the Nasdaq granted time until Feb. 25, 2025, to file its&nbsp;annual report on Form 10-K for the fiscal year ending June 30, 2024, and its quarterly report on Form 10-Q for the period ending Sept. 30, 2024.&nbsp;Reacting to the news,&nbsp;the company’s shares rose as much as 9.3% intraday on Monday before giving back most of the gains. At the close, the stock was up 0.52% at $44.16.&nbsp;Tuesday’s weakness comes amid lingering worries about whether Super Micro can meet the late-February deadline and the declines in some AI-levered stocks.Retail, however, is optimistic. A poll run by Stocktwits showed that 84% of the respondents expected Super Micro to file its quarterly report by the Nasdaq-granted deadline.&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_poll_9ad2e4c39f.png" alt="smci_poll.png">Among AI news flow, Taiwan Semiconductor Manufacturing Co. Ltd. (<a class="mention" data-mention="$TSM" data-symbol-id="TSM" href="https://stocktwits.com/symbol/TSM" target="_blank">$TSM</a>), the world’s biggest chip supplier, reported a 12% month-over-month drop in November revenue.&nbsp; On a year-over-year basis, revenue was up a solid 34% but the stock slipped over 2%.Shares of enterprise AI software applications company c3.ai, Inc. ($AI) were down about 0.50% after it widened its full-year loss guidance. The 10-Q report filed with the SEC showed CEO Thomas Siebel adopted a plan to sell 12.78 million Class A shares of the company, with the plan set to expire by Dec. 17, 2026.Retail sentiment toward Super&nbsp;Micro’s stock improved from ‘bearish’ a day ago to ‘bullish’ (60/100), with message volume remaining ‘normal.’<figure class="image"><img style="aspect-ratio:642/133;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_sentiment_f6c64ef7ef.png" alt="smci-sentiment.png" width="642" height="133"><figcaption>SMCI sentiment and message volume December 10, 2024, as of 11:33 am ET | Source:&nbsp;Stocktwits</figcaption></figure>A Stocktwits user saw the plunge as normal for volatile stocks, especially after big run-ups.<stembedurl>https://stocktwits.com/Kevothe1/message/595862316</stembedurl>Another said he would use the opportunity to “re-load.”&nbsp;<stembedurl>https://stocktwits.com/postrade/message/595862248</stembedurl>Notwithstanding the stock volatility,&nbsp;Super Micro’s shares are&nbsp;up over 55% for the year, although they are trading&nbsp;well off the March 8 intraday high of $122.90.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Super Micro Computer, Inc. (Supermicro) logo appears on the screen of a smartphone in Reno, United States, on December 7, 2024.

Super Micro’s Volatile Run Continues As Stock Teeters Around $40 Following 9% Drop: Retail Turns Constructive

Tuesday’s weakness comes amid lingering worries about whether Super Micro can meet the late-February deadline and the declines in some AI-levered stocks.

First Trust Exchange-Traded Fund - First Trust NASDAQ-100 Technology Sector Index Fund

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

QTEC
First Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest QTEC News

QTECFirst Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund